ADAMTS13 and stroke disorder: One of the more provocative findings from observational studies is the association of lower remission ADAMTS13 activity in iTTP survivors with a number of adverse health outcomes, including stroke [15], silent cerebral infarction [35], and a trend towards higher all-cause mortality [12].